We are live on ! Find out more
LAB icon

Standard BioTools
LAB

131 hedge funds and large institutions have $854M invested in Standard BioTools in 2019 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 60 increasing their positions, 17 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

655% more call options, than puts

Call options by funds: $302K | Put options by funds: $40K

253% more repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 17

213% more first-time investments, than exits

New positions opened: 47 | Existing positions closed: 15

103% more capital invested

Capital invested by funds: $422M → $854M (+$433M)

32% more funds holding

Funds holding: 99 → 131 (+32)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

8.31% less ownership

Funds ownership: 101.5% → 93.19% (-8.3%)

Holders
131
Holders Change
+32
Holders Change %
+32.32%
% of All Funds
2.84%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
47
Increased
60
Reduced
17
Closed
15
Calls
$302K
Puts
$40K
Net Calls
+$262K
Net Calls Change
-$9K

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$19.2M
2
PHS
PFM Health Sciences
California
+$15.2M
3
RI
RTW Investments
New York
+$11M
4
Deutsche Bank
Deutsche Bank
Germany
+$10.8M
5
Renaissance Technologies
Renaissance Technologies
New York
+$9.64M

Top Sellers

1
LCS
Levin Capital Strategies
New York
-$98.9M
2
HVC
Healthcare Value Capital
New Jersey
-$3.88M
3
ICM
Indaba Capital Management
California
-$3.45M
4
PVI
Pura Vida Investments
New York
-$2.73M
5
Neuberger Berman Group
Neuberger Berman Group
New York
-$2.64M
Name Holding Trade Value Shares
Change 		Change in
Stake
SCA
76
Secor Capital Advisors
New York
$673K +$533K +50,610 New
TI
77
Trexquant Investment
Connecticut
$645K +$369K +35,025 +259%
PA
78
Perceptive Advisors
New York
$612K +$485K +46,030 New
PGCM
79
Prescott Group Capital Management
Oklahoma
$611K +$485K +46,000 New
RhumbLine Advisers
80
RhumbLine Advisers
Massachusetts
$539K +$64.2K +6,094 +18%
Nisa Investment Advisors
81
Nisa Investment Advisors
Missouri
$420K – – –
Barclays
82
Barclays
United Kingdom
$408K +$323K +30,685 +65,287%
Bank of America
83
Bank of America
North Carolina
$394K +$160K +15,204 +105%
USAA
84
United Services Automobile Association
Texas
$387K +$182K +17,290 +146%
Walleye Trading
85
Walleye Trading
New York
$385K +$149K +14,100 +95%
CANY
86
Caxton Associates (New York)
New York
$371K +$294K +27,920 New
State Board of Administration of Florida Retirement System
87
State Board of Administration of Florida Retirement System
Florida
$364K – – –
QT
88
Quantbot Technologies
New York
$363K +$288K +27,363 New
TA
89
Tiedemann Advisors
New York
$359K -$17.6K -1,666 -6%
FQ
90
First Quadrant
California
$347K +$275K +26,112 New
BCM
91
Bayesian Capital Management
New York
$344K +$273K +25,870 New
BWM
92
BerganKDV Wealth Management
Minnesota
$332K +$264K +25,000 New
DTL
93
Dynamic Technology Lab
Singapore
$306K +$242K +22,990 New
NIT
94
NumerixS Investment Technologies
British Columbia, Canada
$288K +$232K +22,000 New
AIG
95
American International Group
New York
$278K +$38.6K +3,661 +21%
Los Angeles Capital Management
96
Los Angeles Capital Management
California
$272K +$216K +20,470 New
Morgan Stanley
97
Morgan Stanley
New York
$253K -$887K -84,153 -82%
MIM
98
MetLife Investment Management
New Jersey
$214K +$170K +16,104 New
Brown Advisory
99
Brown Advisory
Maryland
$212K +$28K +2,657 +20%
ECM
100
Element Capital Management
New York
$199K +$158K +14,949 New
2 3
4
5 6

LAB Hedge Fund Activity: Q1 2019 in Review

131 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q1 2019, worth a combined $854M — up 103% from $422M a quarter earlier.

Buyers outnumbered sellers: 47 funds opened new LAB positions and 15 closed out — a net gain of 32 holders — while 60 added to existing stakes and 17 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $19.2M. The largest seller was Levin Capital Strategies, cutting an estimated $98.9M.

  • 131 institutional investors held Standard BioTools (LAB) as of Q1 2019, up from 99 in Q4 2018.
  • Funds reported $854M of Standard BioTools stock for Q1 2019, up 103% quarter-over-quarter.
  • 47 funds opened new Standard BioTools positions in Q1 2019 and 15 closed out, a net change of +32 holders.
  • The largest Standard BioTools buyer in Q1 2019 was Fidelity Investments, an estimated $19.2M added.
  • The largest Standard BioTools seller in Q1 2019 was Levin Capital Strategies, an estimated $98.9M sold.

Based on aggregated 13F filings for Q1 2019.